Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
DBGen Ocular Genomics | RCV001725801 | SCV001960895 | pathogenic | Usher syndrome type 2A | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002032683 | SCV002157180 | pathogenic | not provided | 2022-05-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with USH2A-related conditions. This variant is present in population databases (rs768367348, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Asn2710Glnfs*7) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV001725801 | SCV004182842 | pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing |